triptolide has been researched along with Osteogenic Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Jin, Y; Kong, L; Song, M; Wei, J; Xiao, X; Zhang, Y | 1 |
| Bian, Z; Fang, X; Jiang, C; Jiang, W; Li, M; Tian, F; Wang, X; Zhang, H; Zhu, L | 2 |
| Banerjee, S; Mackenzie, TN; Saluja, AK; Sangwan, V; Subramanian, S; Thayanithy, V | 1 |
| Li, J; Li, SG; Ling, CQ; Shi, QW | 1 |
| An, HK; Kim, HJ; Kim, KS; Kwon, HY; Lee, YC; Moon, HI | 1 |
| Chen, L; Zhang, Q; Zhao, X | 1 |
7 other study(ies) available for triptolide and Osteogenic Sarcoma
| Article | Year |
|---|---|
Network pharmacology, molecular docking and bioinformatics reveal the mechanism of Tripterygii Wilfordii against Osteosarcoma.
Topics: Bone Neoplasms; Computational Biology; Drugs, Chinese Herbal; Humans; Kaempferols; Medicine, Chinese Traditional; Molecular Docking Simulation; Network Pharmacology; Osteosarcoma | 2022 |
Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Diterpenes; Epithelial-Mesenchymal Transition; Epoxy Compounds; Humans; MicroRNAs; Neoplasm Invasiveness; Osteosarcoma; Phenanthrenes; PTEN Phosphohydrolase | 2017 |
Minnelide reduces tumor burden in preclinical models of osteosarcoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Caspase 3; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Survival; Diterpenes; Down-Regulation; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; NF-kappa B; Organophosphates; Osteoblasts; Osteosarcoma; Phenanthrenes; Proto-Oncogene Proteins c-myc; Survivin; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
[Anti-tumor effects of triptolide on osteosarcoma cells in vitro and in vivo: an experimental research].
Topics: Animals; Apoptosis; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Phenanthrenes; Xenograft Model Antitumor Assays | 2013 |
Triptolide induces apoptosis through extrinsic and intrinsic pathways in human osteosarcoma U2OS cells.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Diterpenes; Enzyme Activation; Epoxy Compounds; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Mitochondria; Osteosarcoma; Phenanthrenes; Poly(ADP-ribose) Polymerases; Proteolysis | 2013 |
Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Caspases; Cell Line, Tumor; Cell Survival; Diterpenes; Epoxy Compounds; Humans; Osteosarcoma; Phenanthrenes; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2016 |
AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
Topics: Animals; Apoptosis; Benzylamines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclams; Diterpenes; Down-Regulation; Epoxy Compounds; Female; Heterocyclic Compounds; Humans; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phenanthrenes; Signal Transduction | 2017 |